HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of M40403, a selective superoxide dismutase mimetic, in myocardial ischaemia and reperfusion injury in vivo.

Abstract
1. Myocardial injury caused by ischaemia and reperfusion comes from multiple pathogenic events, including endothelial damage, neutrophil extravasation into tissue, mast cell activation, and peroxidation of cell membrane lipids. These events are followed by myocardial cell alterations resulting eventually in cell necrosis. An enhanced formation of reactive oxygen species is widely accepted as a stimulus for tissue destruction and cardiac failure. 2. In this study, we have investigated the cardioprotective effects of M40403 in myocardial ischaemia-reperfusion injury. M40403 is a low molecular weight, synthetic manganese containing superoxide dismutase mimetic (SODm) that selectively removes superoxide anion. Ischaemia was induced in rat hearts in vivo by ligating the left anterior descending coronary artery. Thirty minutes after the induction of ischaemia, the ligature was removed and reperfusion allowed to occur for at least 60 min. M40403 (0.1-1 mg kg(-1)) was given intravenously 15 min before ischaemia. 3. The results obtained in this study showed that M40403 significantly reduced the extent of myocardial damage, mast cell degranulation and the incidence of ventricular arrhythmias. Furthermore, M40403 significantly attenuated, in a dose-dependent manner, neutrophil infiltration in the myocardium as well as the associated induction of lipid peroxidation. Calcium overload seen post-reperfusion of the ischaemic myocardium was also reduced by M40403. 4. Immunohistochemical analysis for nitrotyrosine revealed a positive staining in cardiac tissue taken after reperfusion: this was attenuated by M40403. Moreover reperfused cardiac tissue sections showed positive staining for P-selectin and for anti-intercellular adhesion molecule (ICAM-1) in the vascular endothelial cells. M40403 treatment markedly reduced the intensity and degree of P-selectin and ICAM-1 in these tissues. No staining for nitrotyrosine, P-selectin or ICAM-1 was found in cardiac tissue taken at the end of the ischaemic period. 5. Overall, M40403 treatment reduced the morphological signs of myocardial cell injury and significantly improved survival. 6. Taken together, these results clearly indicate that M40403 treatment exerts a protective effect against ischaemia-reperfusion-induced myocardial injury, supporting a key role for superoxide anion in reperfusion injuries. This suggests that synthetic enzymes of SOD such as M40403, offer a novel therapeutic approach for the treatment of ischaemic heart disease where superoxide anion plays a dominant role.
AuthorsEmanuela Masini, Salvatore Cuzzocrea, Emanuela Mazzon, Cosimo Marzocca, Pier Francesco Mannaioni, Daniela Salvemini
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 136 Issue 6 Pg. 905-17 (Jul 2002) ISSN: 0007-1188 [Print] England
PMID12110615 (Publication Type: Journal Article)
CopyrightBritish Journal of Pharmacology (2002) 136, 905-917
Chemical References
  • Cardiotonic Agents
  • Organometallic Compounds
  • P-Selectin
  • Intercellular Adhesion Molecule-1
  • imisopasem manganese
  • 3-nitrotyrosine
  • Tyrosine
  • Manganese
  • Peroxidase
  • Superoxide Dismutase
Topics
  • Animals
  • Cardiotonic Agents (pharmacology, therapeutic use)
  • Immunohistochemistry
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Male
  • Manganese
  • Molecular Mimicry
  • Myocardial Ischemia (metabolism, pathology, prevention & control)
  • Myocardial Reperfusion Injury (metabolism, pathology, prevention & control)
  • Organometallic Compounds (chemistry, pharmacology, therapeutic use)
  • P-Selectin (metabolism)
  • Peroxidase (metabolism)
  • Rats
  • Rats, Wistar
  • Superoxide Dismutase (chemistry)
  • Tyrosine (analogs & derivatives, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: